Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.

Journal of law and medicine - 1 Aug 2006

Abbot John

Abstract excerpt

The breadth of claims in patents relating to genetic inventions has been controversial for some time. Possible adverse effects of broad claims include inhibiting research and higher costs, restricting patient access to genetic testing. The Australian Law Reform Commission's Report on Genes and Ingenuity--Gene Patenting and Human Health examined this issue, and concluded that the existing disclosure requirements...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to Biotechnology
Share to Data Collection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disclosure

Share to Genetic Research

Share to Genetic Testing

Share to Patents as Topic

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 16937785

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.PMID 16937785Read ↗

Law-medicine interfacing: patenting of human genes and mutations.Semantic proximity Read ↗

Legal developments and practical implications of gene patenting on targeted drug discovery and development.Semantic proximity Read ↗

The impact of patents on the development of genome-based clinical diagnostics: an analysis of case studies.Semantic proximity Read ↗

Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.Semantic proximity Read ↗

Patents, genomics, research, and diagnostics.Semantic proximity Read ↗

Patents in Genomics and Human GeneticsSemantic proximity Read ↗

Intellectual property. Patents on human genes: an analysis of scope and claims.Semantic proximity Read ↗

The fate and future of patents on human genes and genetic diagnostic methods.Semantic proximity Read ↗

Patenting genetic diagnostic methods: NGS, GWAS, SNPs and patents.Semantic proximity Read ↗

Trends in Human Gene Patent LitigationSemantic proximity Read ↗

Gene patents at the Supreme Court: Association for Molecular Pathology v. Myriad GeneticsSemantic proximity Read ↗

Myriad Genetics: In the eye of the policy storm.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.